Current therapy for malignant melanoma.

  title={Current therapy for malignant melanoma.},
  author={Sewa S. Legha},
  journal={Seminars in oncology},
  volume={16 1 Suppl 1},
The majority of patients with stage I melanoma can be cured with surgery. Extension of tumor to the regional lymph nodes portends a poor prognosis, with an expected 5-year survival rate of no more than 20% to 25%. Adjuvant therapy has not been particularly useful in such patients. Patients with metastatic melanoma generally do poorly and have a median survival of 4 to 6 months. Such patients are treated with systemic therapy unless they have a surgically resectable single site of metastasis, in… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 25 extracted citations

Cytochrome P450-activated prodrugs.

Future medicinal chemistry • 2013
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…